5 Best Low Price Pharma Stocks To Invest In

In this piece, we will take a look at the five best low price pharma stocks to invest in. If you want to learn more about all the recent developments in the pharma industry, check out 11 Best Low Price Pharma Stocks To Invest In.

5. Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD)

Number of Hedge Fund Investors In Q4 2023: 30

Share Price: $7.79

Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) is an American firm headquartered in Boston, Massachusetts. It makes and sells treatments for gastric system disorders such as irritable bowel syndrome. The firm scored a win in March 2024 when its treatment for a rare bowel disease called Small Bowel Syndrome (SBS) demonstrated stable outcomes in testing.

As of Q4 2023 end, 30 out of the 933 hedge funds covered by Insider Monkey had bought and owned Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD)’s shares. Alex Denner’s Sarissa Capital Management was the firm’s biggest investor due to its $187 million investment.

4. Bausch Health Companies Inc. (NYSE:BHC)

Number of Hedge Fund Investors In Q4 2023: 31

Share Price: $8.63

Bausch Health Companies Inc. (NYSE:BHC) is a sizeable American pharmaceutical company whose products cover a variety of ailments such as those of the liver and the skin. The firm scored a win in April 2024 when a court stopped a rival company from selling a generic drug.

Insider Monkey dug through 933 hedge funds for their fourth quarter of 2023 shareholdings and found that 31 had invested in the firm. Bausch Health Companies Inc. (NYSE:BHC)’s largest hedge fund shareholder is Carl Icahn’s Icahn Capital LP through its $278 million stake.

3. Elanco Animal Health Incorporated (NYSE:ELAN)

Number of Hedge Fund Investors In Q4 2023: 35

Share Price: $13.87

Elanco Animal Health Incorporated (NYSE:ELAN) focuses primarily on making and selling products that deal with animal health. The firm’s shares are rated Overweight on average, and the average analyst share price target is $17.76 according to the WSJ.

For their December quarter of 2023 shareholdings, 35 out of the 933 hedge funds covered by Insider Monkey’s survey were Elanco Animal Health Incorporated (NYSE:ELAN)’s shareholders. Frederick Disanto’s Ancora Advisors owned the biggest stake which was worth $156 million.

2. Viatris Inc. (NASDAQ:VTRS)

Number of Hedge Fund Investors In Q4 2023: 43

Share Price: $11.32

Viatris Inc. (NASDAQ:VTRS) is a diversified pharmaceutical company that makes and sells both specialty and generic drugs. It started off April 2024 on a strong note when a court allowed it to challenge pharma giant JNJ’s Schizophrenia treatment patent.

During last year’s fourth quarter, 43 out of the 933 hedge funds part of Insider Monkey’s database had invested in the firm. Viatris Inc. (NASDAQ:VTRS)’s largest investor among these is James E. Flynn’s Deerfield Management due to its $215 million investment.

1. Teva Pharmaceutical Industries Limited (NYSE:TEVA)

Number of Hedge Fund Investors In Q4 2023: 50

Share Price: $13.23

Teva Pharmaceutical Industries Limited (NYSE:TEVA) is one of the biggest companies on our list with more than thirty thousand employees. It is also challenging JNJ’s Schizophrenia treatment, and in April 2024, the firm revealed that its migraine drug performed well in China.

50 out of the 933 hedge funds profiled by Insider Monkey were Teva Pharmaceutical Industries Limited (NYSE:TEVA)’s shareholders. David Greenspan’s Slate Path Capital owned the biggest stake which was worth $273 million.

Disclosure: None. You can also take a look at the 16 Best Dividend Stocks of All Time and Warren Buffett’s Portfolio: 15 Longest Held Stocks.

Insider Monkey focuses on uncovering the best investment ideas of hedge funds and investors. Please subscribe to our daily free newsletter to get the latest investment ideas from hedge funds’ investor letters by entering your email address below.

Follow Insider Monkey on Twitter